Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 21,363 | 23,769 | 24,502 | 24,509 | 22,189 |
| Operating Income | -21,363 | -23,769 | -24,502 | -24,509 | -22,189 |
| Interest Expense | 3,819 | 3,648 | 3,365 | 2,061 | 522 |
| Other Income | 677 | 323 | 98 | 27 | 29 |
| Pre-tax Income | -24,505 | -27,094 | -27,769 | -26,543 | -22,682 |
| Net Income Continuous | -24,505 | -27,094 | -27,769 | -26,543 | -22,682 |
| Net Income | $-24,505 | $-27,094 | $-27,769 | $-26,543 | $-22,682 |
| EPS Basic Total Ops | -0.28 | -0.31 | -0.32 | -0.35 | -0.33 |
| EPS Basic Continuous Ops | -0.28 | -0.31 | -0.32 | -0.35 | -0.33 |
| EPS Diluted Total Ops | -0.28 | -0.31 | -0.32 | -0.35 | -0.33 |
| EPS Diluted Continuous Ops | -0.28 | -0.31 | -0.32 | -0.35 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.31 | -0.32 | N/A | N/A |
| EBITDA(a) | $-21,496 | $-23,694 | $-24,202 | $-23,718 | $-22,439 |